Pulmonary Hypertension Surveillance
暂无分享,去创建一个
Mary G. George | Shaleah Levant | Linda J. Schieb | C. Ayala | Shaleah Levant | Carma Ayala | Anjali Talwalkar | Linda Schieb | Anjali Talwalkar
[1] H M Rosenberg,et al. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[2] S. Rich,et al. The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenograms from the NHANES II Survey. , 1989, Chest.
[3] S. Rich,et al. Pulmonary hypertension--advances in medical and surgical interventions. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] M. Humbert,et al. A critical analysis of survival in pulmonary arterial hypertension , 2012, European Respiratory Review.
[5] M. J. Hall,et al. National Hospital Discharge Survey: 2007 summary. , 2010, National health statistics reports.
[6] Roderick C Deaño,et al. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. , 2013, JAMA internal medicine.
[7] H. Olschewski,et al. [Pulmonary hypertension]. , 2012, Deutsche medizinische Wochenschrift.
[8] G. Raskob,et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. , 2010, Chest.
[9] J. Krishnan,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[10] M. Mcgoon,et al. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. , 2013, Chest.
[11] Barst Rj. Role of atrial septostomy in the treatment of pulmonary vascular disease , 2000 .
[12] George A Mensah,et al. Pulmonary hypertension surveillance--United States, 1980-2002. , 2005, Morbidity and mortality weekly report. Surveillance summaries.
[13] G. Raskob,et al. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. , 2011, Chest.
[14] R A Israel,et al. Analytical potential for multiple cause-of-death data. , 1986, American journal of epidemiology.
[15] H. Kiss,et al. Primary pulmonary hypertenson in pregnancy: A case report , 1995 .
[16] W. Seeger,et al. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[17] J Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.
[18] J. Alpert,et al. Pulmonary hypertension: hemodynamic diagnosis and management. , 2002, Archives of internal medicine.
[19] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[20] D. Lilienfeld,et al. Mortality from primary pulmonary hypertension in the United States, 1979-1996. , 2000, Chest.
[21] D. Lilienfeld,et al. Increased mortality in African Americans with idiopathic pulmonary arterial hypertension. , 2008, Journal of the National Medical Association.
[22] A. Di Matteo,et al. Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: prospective study of 10 patients , 2003, AIDS.
[23] R. Speich,et al. Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[24] E. Graves. National Hospital Discharge Survey. , 1989, Vital and health statistics. Series 13, Data from the National Health Survey.
[25] Horst Olschewski,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[26] G. Simonneau,et al. New treatments for pulmonary arterial hypertension. , 2002, American journal of respiratory and critical care medicine.
[27] S. Rich. Clinical insights into the pathogenesis of primary pulmonary hypertension. , 1998, Chest.
[28] J. Lordan,et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. , 2012, American journal of respiratory and critical care medicine.
[29] N. Lee,et al. Diagnosis and assessment of pulmonary arterial hypertension , 2010 .
[30] L. Chung,et al. Epidemiology and Risk Factors for Pulmonary Hypertension in Systemic Sclerosis , 2012, Current Rheumatology Reports.
[31] G. Raskob,et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. , 2008, Mayo Clinic proceedings.
[32] L. Monnery,et al. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. , 2001, British journal of anaesthesia.
[33] R. Barst,et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. , 2005, The American journal of cardiology.
[34] S. Archer,et al. Evolving epidemiology of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[35] M. Humbert,et al. A decade of achievement in pulmonary hypertension , 2011, European Respiratory Review.
[36] J. Afilalo,et al. Pulmonary Arterial Hypertension in the Elderly-Clinical Characteristics and Long-Term Survival , 2012, Lung.
[37] E. Arias,et al. The validity of race and Hispanic origin reporting on death certificates in the United States. , 2008, Vital and health statistics. Series 2, Data evaluation and methods research.
[38] S. Kimmel,et al. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. , 2003, Chest.
[39] G. Parati,et al. Pulmonary hypertension in CKD. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[40] Susan O Griffin,et al. Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. , 2005, Morbidity and mortality weekly report. Surveillance summaries.
[41] A. Torbicki,et al. Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[42] H. Ghofrani,et al. Mechanisms of disease: pulmonary arterial hypertension , 2011, Nature Reviews Cardiology.
[43] Kozak Lj. Underreporting of race in the National Hospital Discharge Survey. , 1995, Advance data.
[44] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[45] K. Chin,et al. International Classification of Diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies. , 2011, Chest.
[46] L. Rubin,et al. Medical and surgical treatment options for pulmonary hypertension. , 1998, The American journal of the medical sciences.
[47] S. Halpern,et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. , 2011, Chest.